Collegium Pharmaceutical's Earnings Outlook

On Thursday, February 25, Collegium Pharmaceutical COLL will release its latest earnings report. Here is Benzinga's outlook for the company.

What Are Earnings, Net Income, And Earnings Per Share?

Earnings and especially earnings per share (EPS) are useful measures of a company's profitability. Total earnings, which is also referred to as net income, equals total revenue minus total expenses. EPS equals to net income divided by the number of shares outstanding.

Earnings And Revenue

Analysts expect Collegium Pharmaceutical earnings of $0.29 per share. Revenue will likely be around $77.41 million, according to the consensus estimate. Collegium Pharmaceutical's loss in the same period a year ago was $0.07 per share. Quarterly sales came in at $74.20 million.

What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?

Analysts who cover this company will publish forward-looking estimates of its revenue and EPS each quarter. Averaging together every EPS and revenue prediction that each analyst makes about a company in a quarter yields the "consensus estimates." A company posting earnings or revenue above or below the consensus estimate is known as an "earnings surprise" and may move the stock by a considerable margin.

The Wall Street estimate would represent a 514.29% increase in the company's earnings. Sales would be up 4.32% from the same quarter last year. Collegium Pharmaceutical's reported EPS has stacked up against analyst estimates in the past like this:

Stock Performance

Shares of Collegium Pharmaceutical were trading at $24.52 as of February 23. Over the last 52-week period, shares are up 15.31%. Given that these returns are generally positive, long-term shareholders can be satisfied going into this earnings release.

Do not be surprised to see the stock move on comments made during its conference call. Collegium Pharmaceutical is scheduled to hold the call at 16:30:00 ET and can be accessed here.